This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...

According to a Securities and Exchange Commission (SEC) filing dated October 16, 2025, ASSET PLANNING SERVICES INC /LA/ /ADV ...

Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...

By stepping out as the first biopharma to win a three-year exemption from President Donald Trump’s earlier-announced plans for 100% tariffs, in return for agreeing to manufacture more of its drugs in ...

Moderna and Pfizer-BioNTech are in a tight race to launch their COVID-19 vaccines in Europe after both applied for emergency EU approval on Tuesday, though there was uncertainty over whether a rollout ...